Kronos Bio, Inc. Restructuring Costs and Asset Impairment Charges
Kronos Bio, Inc. reported Restructuring Costs and Asset Impairment Charges of $3.07 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:RestructuringCostsAndAssetImpairmentCharges · last filed 2025-05-08
- Kronos Bio, Inc. restructuring costs and asset impairment charges for the quarter ending 2025-03-31 was $3.07M, a 72.52% decline year-over-year.
- Kronos Bio, Inc. restructuring costs and asset impairment charges for the quarter ending 2024-12-31 was $15.88M, a 6301.21% increase year-over-year.
- Kronos Bio, Inc. restructuring costs and asset impairment charges for the quarter ending 2024-09-30 was $39.00K.
- Kronos Bio, Inc. restructuring costs and asset impairment charges for the quarter ending 2024-06-30 was $553.00K, a 81.04% decline year-over-year.
- Kronos Bio, Inc. restructuring costs and asset impairment charges for fiscal 2024 was $27.63M, a 773.36% increase from fiscal 2023.
- Kronos Bio, Inc. restructuring costs and asset impairment charges for fiscal 2023 was $3.16M.
| Period end | Restructuring Costs and Asset Impairment Charges 3 month | Restructuring Costs and Asset Impairment Charges 6 month | Restructuring Costs and Asset Impairment Charges 9 month | Restructuring Costs and Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2025-03-31 | $3.07M 10-Q · filed 2025-05-08 | $18.94M derived: sum of 2 quarters · filed 2025-05-08 | $18.98M derived: sum of 3 quarters · filed 2025-05-08 | $19.54M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | $15.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $15.91M derived: sum of 2 quarters · filed 2025-03-18 | $16.47M derived: sum of 3 quarters · filed 2025-03-18 | $27.63M 10-K · filed 2025-03-18 |
| 2024-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $592.00K derived: sum of 2 quarters · filed 2024-11-13 | $11.76M 10-Q · filed 2024-11-13 | $12.01M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-06-30 | $553.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $11.72M 10-Q · filed 2024-08-08 | $11.97M derived: sum of 3 quarters · filed 2025-05-08 | $11.97M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-03-31 | $11.17M 10-Q · filed 2025-05-08 | $11.41M derived: sum of 2 quarters · filed 2025-05-08 | $11.41M derived: sum of 3 quarters · filed 2025-05-08 | $14.33M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $248.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $248.00K derived: sum of 2 quarters · filed 2025-03-18 | $3.16M derived: sum of 3 quarters · filed 2025-03-18 | $3.16M 10-K · filed 2025-03-18 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $2.92M derived: sum of 2 quarters · filed 2024-11-13 | $2.92M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $2.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.92M 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 |